Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase

International Journal of Biochemistry and Cell Biology

Volumn 28, Issue 10, 1996, Pages 1141-1150

  Marchina, Eleonora ^a   Barlati, Sergio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRONECTIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION;

EID: 0030272712     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-2725(96)00055-6     Document Type: Article

References (49)

1. Barlati S., De Petro G., Colombi M., Rebessi L., Adamoli A., Brega A. and Mignatti P. (1988) Transformation enhancing factors in vitro and in vivo potential as cancer markers. The Cancer J. 2, 95-104.
2. Barlati S., Marchina E., Quaranta C. A., Vigasio F. and Semeraro F. (1990) Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair. Exp. Eye Res. 51, 1-9.
3. Barlati S. (1994) Plasminogen activators and fibronectin fragments in tumor growth and signal transduction. Bull. Inst. Pasteur 92, 269-275.
4. Barlati S., Colombi M. and De Petro G. (1995) Differential expression of fibronectin and its degradation products in malignant tumors. In Tumor Matrix Biology (Edited by Róza Ádány), pp. 81-99. CRC Press, Boca Raton, Florida.
5. Chen W. T., Olden K., Bernard B. A. and Chu F. F. (1984) Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites. J. Cell Biol. 98, 1546-1555.
6. Clark R. A. F. (1988) Potential roles of fibronectin in cutaneous wound repair. Arch. Dermatol. 124, 201-206.
7. Danø K., Andreasen P. A., Grø J., Kristensen P., Nielson S. L. and Skriver L. (1985) Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44, 139-266.
8. De Petro G., Barlati S., Vartio T. and Vaheri A. (1981) Transformation-enhancing activity of gelatin-binding fragments of fibronectin. Proc. Natl Acad. Sci. USA 78, 4965-4969.
9. De Petro G., Barlati S., Vartio T. and Vaheri A. (1983) Transformation-enhancing activity in plasma of tumor patients: relationship with fibronectin fragments. Int. J. Cancer 31, 157-162.
10. De Petro G. and Barlati S. (1987) Characterization of fibronectin fragments and plasminogen activators released by RSV-transformed cells. Fibrinolysis 1, 183-187.
11. De Petro G., Copeta A. and Barlati S, (1994) Urokinase-type and tissue-type plasminogen activators as growth factors for human fibroblasts. Exp. Cell Res. 213, 286-294.
12. Fritz L. and Wunderer G. (1983) Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arznei Forsch. Drug Res. 33, 479-494.
13. Gold L. J., Rostagno A., Frangione B. and Passalaris T. (1992) Localization of the cleavage sites on fibronectin following digestion by urokinase. J. Cell Biochem. 50, 441-452.
14. Grinnell F., Ho C. H. and Wysocki A. (1992) Degradation of vibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting and cell adhesion assays. J. Invest. Dermatol. 98, 410-416.
15. He C. J., Rebibon J. M., Peraldi M. N., Meulders Q. and Rondeau E. (1991) Growth factor like effect of urokinase type plasminogen activator in human renal cells. Bichem. Biophys. Res. Commun. 176, 1408-1416.
16. Herbert J. M., Lamarche I., Prabonnaud V., Dol F. and Gauthier T. (1994) Tissue type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J. Biol. Chem. 269, 3076-3080.
17. Hocking D. C., Sottile J. and McKeown-Longo P. J. (1994) Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin. J. Biol. Chem. 269, 19183-19191.
18. Humphries M. J., Obara M., Olden K. and Yamada K. M. (1989) Role of fibronectin in adhesion, migration, and metastasis. Cancer Invest. 7, 373-393.
19. Hynes R. (1985) Molecular biology of fibronectin. Ann. Rev. Cell Biol. 1, 67-90.
20. Kircheimer J. C., Wojta J., Christ G., Hienert G. and Binder B. R. (1988) Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells. Carcinogenesis 9, 2121-2123.
21. La Cell P., Blumenstock F. A. and Saba T. M. (1991) Blood-borne fragments of fibronectin after thermal injury. Blood 77, 2037-2041.
22. 4. Nature 227, 680-685.
23. Leary J., Brigatti J. and Ward D. (1983) Rapid and sensitive colorimetric method for visualizing biotin labelled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: bio-blots. Proc. Natl Acad. Sci. USA 80, 4045-4049.
24. Liu J. and Gurewich V. (1995) Inactivation of the intrinsic activity of pro-urokinase by diisopropyl fluorophosphate is reversible. J. Biol. Chem. 270, 8408-8410.
25. Marchina E., De Petro G. and Barlati S. (1993) Interaction of tissue-type plasminogen activator with fibronectin and fibronectin fragments. Fibrinolysis 7, 51-57.
26. McDonald J. A. (1988) Extracellular matrix assembly. Ann. Rev. Cell Biol. 4, 183-207.
27. McGuire P. G. and Seeds N. W. (1990) Degradation of underlying extracellular matrix by sensory neurons during neurite outgrowth. Neuron 4, 633-642.
28. Mignatti P. and Rifkin D. B. (1993) Biology and biochemistry or proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
29. Moro L., Colombi M., Crespi S., Di Lernia R. and Barlati S. (1990) Study of fibronectin expression in tumor cells by dot-blot and in situ hybridization: quantitative evaluation by image analysis. Cell Biol. Int. Rep. 14, 701-715.
30. Moro L., Colombi M., Molinari Tosatti M. P. and Barlati S. (1992) Study of fibronectin mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization. Int. J. Cancer 51, 692-697.
31. Naldini L., Vigna E., Bardarelli A., Follenzi A., Galimi F. and Comoglio P. M. (1995) Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by stoichiometric reaction. J. Biol. Chem. 270, 603-611.
32. Norris D. A., Clark R. A. F., Swigart L. M., Huff J. C., Weston W. L. and Howell S. E. (1982) Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J. Immunol. 129, 1612-1618.
33. Orsini G., Brandazza A., Sarmientos P., Molinari A., Lansen J. and Cauet G. (1991) Efficient renaturation and fibrinolytic properties of prourokinase and a deletion mutant expressed in Escherichia coli as inclusion bodies. Eur. J. Biochem. 195, 691-697.
34. Pesciotta Peters D. M., Portz L. M., Fullenwider J. and Mosher D. F. (1990) Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblasts cultures. J. Cell Biol. 111, 249-256.
35. Pöllänen J., Stephens R. W. and Vaheri A. (1991) Directed plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res. 57, 273-328.
36. Quigley J. P., Gold L. I., Schwimmer R. and Sullivan L. M. (1987) Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc. Natl Acad. Sci. USA 4, 2776-2780.
37. Rabbani S. A., Mazar A. P., Bernier S. M., Haq M., Bolivar I., Henkin J. and Goltzman D. (1992) Structural requirements for the growth factor activity of the ammo-terminal domain of urokinase. J. Biol. Chem. 276, 14151-14156.
38. Ruoslahti E., Engvall E. and Hayman G. (1981) Fibronectin: current concepts of its structure and functions. Coll. Res. 1, 95-128.
39. 2-macroglobulin produced by cultured normal and malignant human cells. Int. J. Cancer 33, 609-616.
40. Salonen E. M., Vartio T., Miggiano V., Stähli C., Takacs B., Virgalitta G., De Petro G., Barlati S. and Vaheri A. (1984) A rapid and highly sensitive solid-phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antiboby. J. Immunol. Meth. 72, 145-156.
41. Salonen E. M., Saksela O., Vartio T., Vaheri A., Nielsen L. S. and Zeuthen J. (1985) Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J. Biol. Chem. 260, 12302-12307.
42. Schmitt M., Jänicke F. and Graeff H. (1992) Tumor-associated proteases. Fibrinolysis 6(4), 3-26.
43. Siefring G. E. and Castellino F. J. (1976) Interaction of streptokinase with plasminogen. J. Biol. Chem. 251, 3913-3920.
44. Sottile J. and Wiley S. (1994) Assembly of amino-terminal fibronectin dimers into the extracellular matrix. J. Biol. Chem. 269, 17192-17198.
45. Sumi Y., Dent M. A. R., Owen D. E., Seeley P. J. and Morris R. J. (1992) The expression of tissue and urokinase-type plasminogen activators in neural development suggest different modes of proteolytic involvement in neuronal growth. Development 116, 625-637.
46. Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350-4354.
47. Vartio T., Salonen E. M., De Petro G., Barlati S., Miggiano V., Stähli C., Virgallita G., Takacs B. and Vaheri A. (1983a) Monoclonal antibody against the N-terminal end of human plasma fibronectin. Biochem. J. 215, 147-152.
48. Vartio T., Barlati S., De Petro G., Miggiano V., Stähli C., Takacs B. and Vaheri A. (1983b) Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them. Eur. J. Biochem. 135, 203-207.
49. Vassalli J. D. and Belin D. (1987) Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett. 214, 187-191.